Trial intelligence / Profile preview

Clonidine versus tranexamic acid for bleeding control during tympanoplasty

IRCT20230523058274N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in tympanic membrane disorder comparing Clonidine preoperative arm with Tranexamic acid preoperative arm (2 arms). Primary endpoints: Reduction in intraoperative bleeding, Surgeon satisfaction during operation and 2 more. Started Jul 2023; status: completed.

02

Drugs

clonidinetranexamic acid
03

Conditions

tympanic membrane disorder

Beyond the preview

Go deeper on IRCT20230523058274N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230523058274N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call